NK Cell Therapy Market Size, Share, Growth, and Industry Analysis, By Types (NK Cell Therapies, NK Cell Directed Antibodies), By Applications (Cancer, Gastrointestinal Diseases, Others) , and Regional Insights and Forecast to 2035

Detailed TOC of Global NK Cell Therapy Market Growth (Status and Outlook) 2026-2035

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global NK Cell Therapy Market Size (2020-2035)
2.1.2 NK Cell Therapy Market Size CAGR by Region (2020 VS 2026 VS 2035)
2.1.3 World Current & Future Analysis for NK Cell Therapy by Country/Region (2020, 2026 & 2035)
2.2 NK Cell Therapy Segment by Type
2.2.1 NK Cell Therapies
2.2.2 NK Cell Directed Antibodies
2.3 NK Cell Therapy Market Size by Type
2.3.1 NK Cell Therapy Market Size CAGR by Type (2020 VS 2026 VS 2035)
2.3.2 Global NK Cell Therapy Market Size Market Share by Type (2020-2026)
2.4 NK Cell Therapy Segment by Application
2.4.1 Cancer
2.4.2 Gastrointestinal Diseases
2.4.3 Others
2.5 NK Cell Therapy Market Size by Application
2.5.1 NK Cell Therapy Market Size CAGR by Application (2020 VS 2026 VS 2035)
2.5.2 Global NK Cell Therapy Market Size Market Share by Application (2020-2026)
3 NK Cell Therapy Market Size by Player
3.1 NK Cell Therapy Market Size Market Share by Player
3.1.1 Global NK Cell Therapy Revenue by Player (2020-2026)
3.1.2 Global NK Cell Therapy Revenue Market Share by Player (2020-2026)
3.2 Global NK Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2026-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NK Cell Therapy by Region
4.1 NK Cell Therapy Market Size by Region (2020-2026)
4.2 Global NK Cell Therapy Annual Revenue by Country/Region (2020-2026)
4.3 Americas NK Cell Therapy Market Size Growth (2020-2026)
4.4 APAC NK Cell Therapy Market Size Growth (2020-2026)
4.5 Europe NK Cell Therapy Market Size Growth (2020-2026)
4.6 Middle East & Africa NK Cell Therapy Market Size Growth (2020-2026)
5 Americas
5.1 Americas NK Cell Therapy Market Size by Country (2020-2026)
5.2 Americas NK Cell Therapy Market Size by Type (2020-2026)
5.3 Americas NK Cell Therapy Market Size by Application (2020-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NK Cell Therapy Market Size by Region (2020-2026)
6.2 APAC NK Cell Therapy Market Size by Type (2020-2026)
6.3 APAC NK Cell Therapy Market Size by Application (2020-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe NK Cell Therapy Market Size by Country (2020-2026)
7.2 Europe NK Cell Therapy Market Size by Type (2020-2026)
7.3 Europe NK Cell Therapy Market Size by Application (2020-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa NK Cell Therapy by Region (2020-2026)
8.2 Middle East & Africa NK Cell Therapy Market Size by Type (2020-2026)
8.3 Middle East & Africa NK Cell Therapy Market Size by Application (2020-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global NK Cell Therapy Market Forecast
10.1 Global NK Cell Therapy Forecast by Region (2026-2035)
10.1.1 Global NK Cell Therapy Forecast by Region (2026-2035)
10.1.2 Americas NK Cell Therapy Forecast
10.1.3 APAC NK Cell Therapy Forecast
10.1.4 Europe NK Cell Therapy Forecast
10.1.5 Middle East & Africa NK Cell Therapy Forecast
10.2 Americas NK Cell Therapy Forecast by Country (2026-2035)
10.2.1 United States Market NK Cell Therapy Forecast
10.2.2 Canada Market NK Cell Therapy Forecast
10.2.3 Mexico Market NK Cell Therapy Forecast
10.2.4 Brazil Market NK Cell Therapy Forecast
10.3 APAC NK Cell Therapy Forecast by Region (2026-2035)
10.3.1 China NK Cell Therapy Market Forecast
10.3.2 Japan Market NK Cell Therapy Forecast
10.3.3 Korea Market NK Cell Therapy Forecast
10.3.4 Southeast Asia Market NK Cell Therapy Forecast
10.3.5 India Market NK Cell Therapy Forecast
10.3.6 Australia Market NK Cell Therapy Forecast
10.4 Europe NK Cell Therapy Forecast by Country (2026-2035)
10.4.1 Germany Market NK Cell Therapy Forecast
10.4.2 France Market NK Cell Therapy Forecast
10.4.3 UK Market NK Cell Therapy Forecast
10.4.4 Italy Market NK Cell Therapy Forecast
10.4.5 Russia Market NK Cell Therapy Forecast
10.5 Middle East & Africa NK Cell Therapy Forecast by Region (2026-2035)
10.5.1 Egypt Market NK Cell Therapy Forecast
10.5.2 South Africa Market NK Cell Therapy Forecast
10.5.3 Israel Market NK Cell Therapy Forecast
10.5.4 Turkey Market NK Cell Therapy Forecast
10.6 Global NK Cell Therapy Forecast by Type (2026-2035)
10.7 Global NK Cell Therapy Forecast by Application (2026-2035)
10.7.1 GCC Countries Market NK Cell Therapy Forecast
11 Key Players Analysis
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Information
11.1.2 Nektar Therapeutics NK Cell Therapy Product Offered
11.1.3 Nektar Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2026)
11.1.4 Nektar Therapeutics Main Business Overview
11.1.5 Nektar Therapeutics Latest Developments
11.2 Innate Pharma SA
11.2.1 Innate Pharma SA Company Information
11.2.2 Innate Pharma SA NK Cell Therapy Product Offered
11.2.3 Innate Pharma SA NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2026)
11.2.4 Innate Pharma SA Main Business Overview
11.2.5 Innate Pharma SA Latest Developments
11.3 Affimed
11.3.1 Affimed Company Information
11.3.2 Affimed NK Cell Therapy Product Offered
11.3.3 Affimed NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2026)
11.3.4 Affimed Main Business Overview
11.3.5 Affimed Latest Developments
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Information
11.4.2 Chipscreen Biosciences NK Cell Therapy Product Offered
11.4.3 Chipscreen Biosciences NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2026)
11.4.4 Chipscreen Biosciences Main Business Overview
11.4.5 Chipscreen Biosciences Latest Developments
11.5 Fate Therapeutics
11.5.1 Fate Therapeutics Company Information
11.5.2 Fate Therapeutics NK Cell Therapy Product Offered
11.5.3 Fate Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2026)
11.5.4 Fate Therapeutics Main Business Overview
11.5.5 Fate Therapeutics Latest Developments
11.6 Glycostem Therapeutics
11.6.1 Glycostem Therapeutics Company Information
11.6.2 Glycostem Therapeutics NK Cell Therapy Product Offered
11.6.3 Glycostem Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2026)
11.6.4 Glycostem Therapeutics Main Business Overview
11.6.5 Glycostem Therapeutics Latest Developments
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Information
11.7.2 Dragonfly Therapeutics NK Cell Therapy Product Offered
11.7.3 Dragonfly Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2026)
11.7.4 Dragonfly Therapeutics Main Business Overview
11.7.5 Dragonfly Therapeutics Latest Developments
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Information
11.8.2 Kiadis Pharma NK Cell Therapy Product Offered
11.8.3 Kiadis Pharma NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2026)
11.8.4 Kiadis Pharma Main Business Overview
11.8.5 Kiadis Pharma Latest Developments
11.9 NantWorks
11.9.1 NantWorks Company Information
11.9.2 NantWorks NK Cell Therapy Product Offered
11.9.3 NantWorks NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2026)
11.9.4 NantWorks Main Business Overview
11.9.5 NantWorks Latest Developments
11.10 Nkarta Therapeutics
11.10.1 Nkarta Therapeutics Company Information
11.10.2 Nkarta Therapeutics NK Cell Therapy Product Offered
11.10.3 Nkarta Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2026)
11.10.4 Nkarta Therapeutics Main Business Overview
11.10.5 Nkarta Therapeutics Latest Developments
11.11 Fortress Biotech
11.11.1 Fortress Biotech Company Information
11.11.2 Fortress Biotech NK Cell Therapy Product Offered
11.11.3 Fortress Biotech NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2026)
11.11.4 Fortress Biotech Main Business Overview
11.11.5 Fortress Biotech Latest Developments
12 Research Findings and Conclusion